Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Open, Non-Comparative Study of the Acceptability and Safety of Paracetamol Oral Paediatric Suspension at 4.8%.

NCT00434681 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00434681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00434681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Open, Non-Comparative Study of the Acceptability and Safety of Paracetamol Oral Paediatric Suspension at 4.8%.
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2006
Completion date
April 30, 2007
Enrollment
48
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fever, pain